The global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market size is predicted to grow from US$ 501 million in 2025 to US$ 1208 million in 2032; it is expected to grow at a CAGR of 13.5% from 2026 to 2032.

In 2024, global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) production reached approximately 1700 tons, with an average global market price of around US$300,000 per ton. In 2024, the global s total production capacity of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) reached 2100 tons. The industry average gross profit margin of this product reached 36%.Nicotinamide mononucleotide (NMN) is a naturally occurring bioactive nucleotide and one of the most direct precursors to nicotinamide adenine dinucleotide (NAD+), an important coenzyme in the human body. Its molecule consists of a nicotinamide group, ribose, and a phosphate group. With age, NAD+ levels in the body decline significantly, which is considered closely related to various age-related functional declines. Theoretically, NMN supplementation can be efficiently absorbed by cells and rapidly converted into NAD+, thereby activating the Sirtuins longevity protein family, which depends on NAD+ for function. Sirtuins play a central role in key physiological processes such as mitochondrial function, DNA repair, cellular energy metabolism, and circadian rhythm regulation. Therefore, it has been extensively researched and commercialized, serving as one of the most representative dietary supplement ingredients in the current anti-aging and metabolic health field.

The nicotinamide mononucleotide (NMN) industry chain has formed a complete chain from research and development to end-consumer. Upstream mainly consists of basic chemical raw material suppliers and specialized technical research institutions, focusing on breakthroughs and optimization of synthesis processes. The midstream is the core production stage, dominated by large biotechnology companies and chemical plants. Through chemical synthesis or enzymatic methods, they conduct large-scale production of NMN raw material powders of varying purities, which are then processed into various dosage forms. The downstream is divided into B2B and B2C markets: B2B includes health supplement brands, cosmetics companies, and research institutions, which process the raw materials into end products or use them for research; B2C reaches global consumers through cross-border e-commerce, online platforms, and offline channels. Strict quality and regulatory oversight permeates the entire industry chain, serving as both a key constraint and driving force for its development.

The market prospects for nicotinamide mononucleotide (NMN) are broad but face key challenges. In the short term, as a dietary supplement, its market size continues to expand driven by global aging and health-conscious consumption trends. Advances in production technology will lead to cost reductions and increased market penetration. Medium-term development heavily relies on breakthroughs in clinical research: results from ongoing human clinical trials, if providing solid evidence regarding its safety and efficacy, will greatly enhance consumer confidence and potentially lead to regulatory easing, such as granting it legal health food status in the Chinese market. In the long term, NMNs development faces two possible paths: First, if clinical evidence is conclusive, it may be upgraded to a prescription drug or medical food for adjuvant treatment of specific diseases, leading to a reassessment of its value. Second, if the primary market remains as a supplement, competition will intensify, requiring brands to build barriers through formula innovation, dosage form optimization, and in-depth functional segmentation. Simultaneously, its application in high-end functional skincare products is also a significant growth driver. Overall, the future of NMN will be shaped by the combined forces of science, regulation, and the market.

United States market for Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) players cover Herbalmax, Genex Formulas, Maac10 Formulas, GeneHarbor, Bontac, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

Infinity Market Research newest research report, the ?Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) Industry Forecast? looks at past sales and reviews total world Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) sales in 2025, providing a comprehensive analysis by region and market sector of projected Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) sales for 2026 through 2032. With Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) industry.

This Insight Report provides a comprehensive analysis of the global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide).

This report presents a comprehensive overview, market shares, and growth opportunities of Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Purity 98%
    Purity <98%
    Segmentation by Manufacturing Process:
    Chemical Synthesis
    Enzyme Catalysis
    Fermentation

Segmentation by Application:

    Pharmaceuticals
    Health Products
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Herbalmax
    Genex Formulas
    Maac10 Formulas
    GeneHarbor
    Bontac
    CELFULL
    Zhongsheng Pharmaceutical
    Mirailab Bioscience
    EffePharm
    Kingdomway
    ?Yaben Chemical?

Key Questions Addressed in this Report

What is the 10-year outlook for the global Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market?
What factors are driving Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) market opportunities vary by end market size?
How does Raw Materials for Longevity Drug NMN (Nicotinamide Mononucleotide) break out by Type, by Application?